Gene · 9935
Papers2,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,529
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyp2e1 protects against OVA-induced allergic rhinitis through the inhibition of Th2 cell activation and differentiation: Mediated by MAFB. | Int Immunopharmacol | 2024 | 38603858 | PubTator, text mining | PubMed |
| The Expression of MAFB Gene in Circulating Monocytes Is Related to Chronic Inflammatory Status in T2DM Patients. | Inflammation | 2024 | 38602607 | PubTator, text mining | PubMed |
| A senescence restriction point acting on chromatin integrates oncogenic signals. | Cell Rep | 2024 | 38568812 | PubTator, text mining | PubMed |
| A case report of multicentric carpotarsal osteolysis syndrome: Depiction of a debilitating disease course. | Am J Med Genet A | 2024 | 38551204 | PubTator, text mining | PubMed |
| Macrophage re-programming by JAK inhibitors relies on MAFB. | Cell Mol Life Sci | 2024 | 38528207 | PubTator, text mining | PubMed |
| Clinical and molecular cytogenetic studies of five new patients with 20q11q12 deletion and review of the literature: Proposition of two critical regions. | Am J Med Genet A | 2024 | 38511524 | PubTator, text mining | PubMed |
| Multicentric carpotarsal osteolysis syndrome with variants of MAFB gene: a case report and literature review. | Pediatr Rheumatol Online J | 2024 | 38481224 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. | Chem Biol Interact | 2024 | 38460933 | PubTator, text mining | PubMed |
| Upregulated Genes in Atrial Fibrillation Blood and the Left Atrium. | Cardiology | 2024 | 38452746 | PubTator, text mining | PubMed |
| Identification of a core transcriptional program driving the human renal mesenchymal-to-epithelial transition. | Dev Cell | 2024 | 38340720 | PubTator, text mining | PubMed |
| Monogenic Causes Identified in 23.68% of Children with Steroid-Resistant Nephrotic Syndrome: A Single-Centre Study. | Kidney Dis (Basel) | 2024 | 38322629 | PubTator, text mining | PubMed |
| Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets. | Mol Med | 2024 | 38310228 | PubTator, text mining | PubMed |
Corrigendum to "Cellular senescence-driven transcriptional reprogramming of the MAFB/NOTCH3 axis activates the PI3K/AKT pathway and promotes osteosarcoma progression" [Genes & Diseases 11 (2024) 952-963]. | Genes Dis | 2024 | 38292197 | PubTator, text mining | PubMed |
| ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells. | Cell Death Discov | 2024 | 38282096 | PubTator, text mining | PubMed |
| Dysregulated lncRNAs regulate human umbilical cord mesenchymal stem cell differentiation into insulin-producing cells by forming a regulatory network with mRNAs. | Stem Cell Res Ther | 2024 | 38273351 | PubTator, text mining | PubMed |
| Potential Role of Macrophage Polarization in the Progression of Hunner-Type Interstitial Cystitis. | Int J Mol Sci | 2024 | 38255860 | PubTator, text mining | PubMed |
| Sox9 regulates alternative splicing and pancreatic beta cell function. | Nat Commun | 2024 | 38238288 | PubTator, text mining | PubMed |
| The roles of tissue resident macrophages in health and cancer. | Exp Hematol Oncol | 2024 | 38229178 | PubTator, text mining | PubMed |
| Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? | Blood Cancer J | 2024 | 38225228 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Multiple Myeloma: Clinical Implications. | Hematol Oncol Clin North Am | 2024 | 38199896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9935/papers?page=7